The formulation of K5 lipogel is manufactured in Italy and complies with the current European Cosmetic's Regulation.

K5 lipogel is lightly perfumed and allergen free and has a PAO (Period After Opening) of 12 months and shell life of 36 months. A light pink color was selected for the lipogel.

Diclofenac 1% Gel

Member of Farmavita.Net team is looking for EU-CTD Dossier with supply for Diclofenac 1% Gel 50 mg for Italian Market.

The Dossier should also contain full clinical studies.

Seeking: Novel new sensations and materials for lip products

A kiss may be just a kiss, but we're looking for unique materials to add to lip products for new lip sensations and
experiences (such as cooling, warming, numbing, tingling and flavors), solutions that can impart prolonged sensate
experiences, and solutions that can impart not-yet-known sensations.

Intermediary Pharma Group from Azerbaijan, is interested in obtaining the following finished pharmaceutical products for permanent partnership with full dossiers for registration:

Ceftriaxon 1g, 0.5g with ligocaine;

Ampicilline +Sulbactam 1.5g with solvent;

Cefotaxime 1g, 0.5g,with lidocaine;

Amikacine.

Bacteria strains and fermentation technologies

Farmavita.Net member is seeking bacteria strains and fermentation technologies to produce the following products Lycopene, Chlortetracycline and Acetylisovaleryltylosin.

I am looking for the competent technology offer for CEFUROXIME ACID. If any one is interested to fell cefuroxime acid technology can contact me. 

- Dr Anand Handa

Demand for  contract manufacture of  evacuated sterile parenteral product

Client of Farmavita.Net is looking for  contract manufacturer for the production evacuated, sterile glass bottles used for autohemotherapy with medical ozone.

Inlicensing opportunities for Indian Market

Unichem Laboratories Limited is a globally operating, India-based pharmaceutical company. We are among the top 25 companies in the Indian market with current turnover exceeding US$ 140 million and presence in key therapeutic segments like Cardio, Diabeto, CNS, Anti-infectives, Gastro-intestinals, Pain management,Respiratory, Dermatology, Nephrology.

Our client is a US company interested in in-licensing generic or branded generic products for sale in US market that are projected to have sales volumes of under 15 million USD.  Therapeutic areas of main interest are CNS - pain, psychiatric, anti-emetic - but other therapeutic areas are also possible.

Amaze, Ltd, a Portuguese Consultancy Company for Pharma Business Development activities is looking for OTC products to a local new company.

We have also a partner looking for ethic products either for CNS or Cardiovascular areas.

For more informations please contact Farmavita.Net team.

AMAZE, Ltd,a Portuguese Consultancy Company acting in Pharma Business Development is looking for in-licensing opportunities to our local clients.

We are seeking for OTC and ethic products in order to support our local pharma activities.

For more informations please contact Farmavita.Net team.

Farmavita.Net member is looking for tacrolimus hard capsules with the BE study matching narrow limits both for the AUC and Cmax (90-111%), fed and fasted.

License-in needs for DROTAVERINE

Client of Farmavita.Net is looking for EU CTD Dossier with bulk supply of  40mg/80mg tablets of drotaverin hydrochloride.

License territory would be Poland. Licensee is established company with well developed sales and distribution capability.   

Agency and distribution partership for branded medicines in China

Farmavita.Net member is  looking for long-term agency and distribution partership of branded anticancer or cardiovascular medicines in China. Neptunus Group was established in 1989, and now it has been one of the famous brands of the health industry in China, the comprehensive competitiveness of which ranks the top in the pharmaceutical industry in China. 

Looking for Capecitabine, 150/500 mg tablets

Registered user of Farmavita.Net is looking for EU CTD Dossier with supply for Capecitabine, 150/500 mg tablets. Product is sought for non-EU markets, where data exclusivity and patents are not in force.